HON vs INMB · P/E 36, rev $9.72B vs rev $50.0K
Honeywell International Inc (HON) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. INMB currently screens at market cap $33.5M.
Not investment advice. Open the HON and INMB stock pages for the full models.
Not investment advice.